Skip to main content
BBC NEWS / BUSINESS
Graphics VersionBBC Sport Home
News Front Page | Africa | Americas | Asia-Pacific | Europe | Middle East | South Asia | UK | Business | Health | Science & Environment | Technology | Entertainment | Also in the news | Have Your Say |
Business Contents:  Your Money | Economy Companies

Friday, 2 March 2007, 07:15 GMT

Viagra firm faces High Court bid

Bottles of Lipitor and Pfizer pills A group of UK drugs wholesalers are seeking an injunction to stop the world's biggest pharmaceutical firm changing the way it supplies medicine.

From Monday, Viagra-maker Pfizer will sell its prescription drugs through just one medical wholesaler, Unichem.

Eight wholesalers have launched the legal action, claiming that the agreement breaches competition law.

US-based Pfizer said the wholesalers were bringing the High Court action only to protect their own interests.

The Office of Fair Trading is already investigating whether Pfizer's move breaks competition rules.

'Worrying'

The Dispensing Doctors Association (DDA) - which represents family GPs prescribing medicines - is supporting the wholesalers in their injunction bid against Pfizer.

DDA chief executive Dr David Baker said there were fears within the wholesaler community that the supply of medicines throughout the UK would be at the mercy of big drugs companies.

"If a single supple chain breaks down there will be nowhere else for us to get Pfizer drugs which is worrying," he told BBC Radio Five Live.

Dr Baker also said that if Pfizer products could only be bought from Unichem, there would be a loss of competition and choice.

"Our members are very unhappy about the loss of choice and competition among wholesalers who do compete very hard for our business," he said.

Prescription charges are fixed by the NHS. But Dr Baker added that as NHS prices are based on what prices are paid for the drugs, prices paid by patients could go up if a single wholesaler was able to charge more.

Pfizer, whose products also include the anti-cholesterol drug Lipitor, said it would defend the legal challenge.

"The wholesalers are acting to protect their commercial interests," it said in a statement.

"The legal challenge may jeopardise supply to patients because wholesalers have been encouraging pharmacists not to sign up with Unichem."

The wholesalers bringing the appeal are AAH Pharmaceuticals, Phoenix Medical, Mawdsley Brookes, Munro Wholesale Medical Supplier, Maltby & Sons, Norchem, PIF Medical Supplies and Sangers (Maidstone).



E-mail this to a friend
Related to this story:
Pfizer 'to axe thousands of jobs' (19 Jan 07 |  Business )
Pfizer to cut 2,200 US sales jobs (29 Nov 06 |  Business )
Expiring patents hit Pfizer sales (20 Jul 06 |  Business )
J&J buys up Pfizer unit for $16bn (26 Jun 06 |  Business )
Pfizer wins Chinese Viagra ruling (05 Jun 06 |  Business )

RELATED INTERNET LINKS
Pfizer
DDA
Unichem
The BBC is not responsible for the content of external internet sites



SEARCH BBC NEWS: 

News Front Page | Africa | Americas | Asia-Pacific | Europe | Middle East | South Asia | UK | Business | Health | Science & Environment | Technology | Entertainment | Also in the news | Have Your Say |
Business Contents:  Your Money | Economy Companies

NewsWatch | Notes | Contact us | About BBC News | Profiles | History

^ Back to top | BBC Sport Home | BBC Homepage | Contact us | Help | ©